GO
Loading...

Johnson & Johnson

More

  • Game Plan for the Week of June 4 Friday, 1 Jun 2007 | 6:57 PM ET

    Next week is conference week and that means companies should have big news for investors. Here’s how to play it.Investing can be confusing. Luckily, Cramer has mapped out some road rules for all you Home Gamers trying to navigate the jungle that is Wall Street. Think of it as "Mad Money 101" –- some fundamental advice to keep in mind as you play the market. Whether you're a first time investor or a seasoned financier, it's always good to remember the basics.

  • Mutual Fund Report: Five-Star Managers Wednesday, 30 May 2007 | 4:24 PM ET

    Don't let the summer doldrums strike your portfolio. We've rounded up several five-star mutual fund managers to offer up on their latest strategies and best investment ideas.

  • Breaking Down the Dow Thursday, 24 May 2007 | 6:10 PM ET

    Cramer thinks this index will climb another thousand points by the end of the year. Owning the stocks that should get it there could do wonders for your portfolio.Investing can be confusing. Luckily, Cramer has mapped out some road rules for all you Home Gamers trying to navigate the jungle that is Wall Street. Think of it as "Mad Money 101" –- some fundamental advice to keep in mind as you play the market. Whether you're a first time investor or a seasoned financier, it's always good to remember the basics.

  • Medtronic Profit Up 10% as ICD Sales Improve Tuesday, 22 May 2007 | 7:42 PM ET

    Medtronic reported a forecast-beating 10% rise in quarterly earnings on Tuesday on strongsales of its vascular, neurology and diabetes products and improving demand for its heart rhythm devices.

  • Most analysts believe the market is due for a modest correction, but many traders are reluctant to sell in the face of strong earnings, massive liquidity and daily deals. "I don't think there's anything to be that bearish about," Stephen Leeb, research chairman for The Complete Investor, told CNBC.com. "There's no recession, valuations are basically very reasonable and there are massive amounts of cash on the sidelines."

  • The Week on Wall Street Friday, 18 May 2007 | 6:28 PM ET

    Stocks ended the week mostly higher as strong economic data, soothing comments from Federal Reserve Chief Ben Bernanke and continued M&A action kept buyers in the market. The Dow Jones Industrial Average closed the week with gains of 1.7% while the S&P 500 traded up 1.1%. Both indexes closed higher for the seventh straight week. Not so for the Nasdaq, however, which fell 0.2%.

  • Billionaire Buying Spree Friday, 18 May 2007 | 6:16 PM ET

    Amid the roaring bull market, three big investors disclose details of some big trades within their huge portfolios.

  • No.1 - Billionaire Boys Go Buying Thursday, 17 May 2007 | 12:52 PM ET

    Over the last 2 days The Street’s most admired investors all revealed they were purchasing more stocks. Warren Buffett, George Soros, Carl Icahn and Eddie Lampert disclosed holdings that ranged from drugs to railroads. Click here to find out exactly what they’re buying and why.

  • It's Time for the Lightning Round! Thursday, 17 May 2007 | 11:52 AM ET

    JPMorgan Chase, Jones Soda, Volcano, Monster Worldwide and more...Investing can be confusing. Luckily, Cramer has mapped out some road rules for all you Home Gamers trying to navigate the jungle that is Wall Street. Think of it as "Mad Money 101" –- some fundamental advice to keep in mind as you play the market. Whether you're a first time investor or a seasoned financier, it's always good to remember the basics.

  • Buffett Divulges Details on Berkshire Railroad Holdings Wednesday, 16 May 2007 | 7:59 PM ET

    Billionaire investor Warren Buffett revealed the names of two railroad stocks recently purchased by his holding company Berkshire Hathaway, according to documents filed with the U.S. Securities and Exchange Commission.

  • Buffett Makes Big Bets on Healthcare, Railroads Wednesday, 16 May 2007 | 7:47 PM ET

    Warren Buffett, known for buying undervalued stocks, is boosting his bet on health care, a sector known more for growth than value.

  • Stocks Stage Broad Rally As Dow Sees Triple-Digit Gains Wednesday, 16 May 2007 | 4:51 PM ET

    Stocks moved broadly higher and the Dow logged triple-digit gains as investors were encouraged by large investments revealed by several billionaire investors. "We're in a bull market without any question," said Ned Riley, CEO of Riley Asset Management. "You can't deny this market because there is so much money being invested."

  • Amgen Shares Drop On More Anemia-Drug Fallout Tuesday, 15 May 2007 | 12:00 PM ET

    Another setback for Amgen anemia-drug franchise sent shares of the No. 1 biotechnology company spiraling down as much as 6.6% on Tuesday -- to a 2-1/2-year low -- as more analysts cut their ratings on the beaten-down stock.

  • Market Misjudges Medical Stock Friday, 11 May 2007 | 6:54 PM ET

    Regulation approval in China recently hurt this company, but Cramer says there's reason to believe the business is on the MEND.Investing can be confusing. Luckily, Cramer has mapped out some road rules for all you Home Gamers trying to navigate the jungle that is Wall Street. Think of it as "Mad Money 101" –- some fundamental advice to keep in mind as you play the market. Whether you're a first time investor or a seasoned financier, it's always good to remember the basics.

  • Stocks ended broadly higher after new economic data raised hopes of a Fed rate cut, and investors were quick to jump back into the market following recent declines. "I'm not surprised to see the market snap back," said Alec Young, market strategist at S&P Equity Research. "The market was kind of overbought -- it was an excellent opportunity for a shakeout."

  • Amgen Shares Fall on Downgrades, Anemia-Drug Ruling Friday, 11 May 2007 | 2:12 PM ET

    Several investment banks slashed their ratings on Amgen shares following the disclosure that a U.S. advisory panel called for marketing restrictions on popular anemia drugs sold by Amgen and Johnson & Johnson.

  • CNBC's Domm: Today's Agenda in the Markets Friday, 11 May 2007 | 8:50 AM ET

    Stocks will take their direction from economic data today after yesterday's drenching from negative April chain store sales took the Dow down 147 points and bit 1.7% off the Nasdaq and 1.4% off the S&P 500. European markets are lower, following overnight weakness in Asian markets.

  • Stocks sold off across the board, and the Dow fell almost 150 points, after mixed economic data prompted investors to book gains.  "A day like today was inevitable," said Michael Cuggino of Permanent Portfolio Funds. "I would caution investors not to get overly concerned based on today's (economic) statistics."

  • FDA Panel Recommends Stricter Labeling on Anemia Drugs Thursday, 10 May 2007 | 4:21 PM ET

    Shares of Amgen and Johnson & Johnson traded lower after a U.S. advisory panel called for marketing restrictions on the companies' popular anemia drugs.

  • Dendreon TV Thursday, 10 May 2007 | 11:35 AM ET

    While I'm watching the webcast of the FDA Advisory Committee Meeting on the anemia drugs (Amgen, Johnson & Johnson), I wanted to hop on my TV versus print soapbox one more time.As I posted yesterday, I had asked a Dendreon spokeswoman for an interview with CEO Dr. Mitchell Gold in the wake of the FDA sending the company an "approvable letter" for its prostate cancer treatment Provenge.

Most Popular Video

Wednesday, 23 Apr 2014 | 10:50 PM ET

Taro Kono, Member of the House of Representatives in Japan's Parliament, says the Liberal Democratic Party (LDP) stands behind Prime Minister Shinzo Abe in pushing for the TPP trade deal.

Wednesday, 23 Apr 2014 | 10:34 PM ET

Charles Li, Chief Executive of Hong Kong Exchanges and Clearing, says the launch of a new commodity trading platform for three metal contracts will facilitate long-term cross-border investments.

Wednesday, 23 Apr 2014 | 10:16 PM ET

David Garrity, Principal at GVA Research, says Apple's decision to raise its dividend and step up its stock buyback program signaled confidence in the tech giant's outlook.